Pain Management
Leading institution will study promise of a new antimicrobial benefit of ON-Q
Published in Clinical Trials Week, July 18th, 2005
I-Flow Corporation (IFLO) announced that the Company will partner with Tulane University Health Sciences Center to conduct an animal study to evaluate the antimicrobial benefits of ON-Q(R). If this research yields positive results, this may expand the use of ON-Q beyond today's labeling of significantly reducing pain and narcotics intake after surgery. The decision to green light the antimicrobial study was based on:
* An analysis of more than 44 ON-Q clinical studies (covering nearly 2,800 patients);
* An extensive literature search that revealed 16 published in vitro studies demonstrating the antimicrobial properties of local anesthetics;
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-07-18)
More Articles from Clinical Trials Week
- Alzheimer Disease
A-beta immunization reduced cerebral volume in Alzheimer disease - Angiology
U.S. trial for atrial fibrillation underway - Anorexia Nervosa
Alendronate shows promise for treatment of osteopenia - Headache and Migraine
Almotriptan effective in patients with poor response to sumatriptan - Acute Vertebrobasilar Occlusion
IV Abciximab, intra-arterial rtPA, and additional PTA/stenting improve outcome - Adrenalectomy
Transperitoneal and retroperitoneal approaches to adrenalectomy evaluated - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
